Cargando…
Microbial Spectrum and Antibiotic Resistance in Patients Suffering from Penetrating Crohn’s Disease
Intraabdominal abscess formation occurs in up to 30% of patients suffering from Crohn´s disease (CD). While international guidelines recommend a step-up approach with a combination of empiric antibiotic therapy and percutaneous drainage to delay or even avoid surgery, evidence about microbial spectr...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330589/ https://www.ncbi.nlm.nih.gov/pubmed/35893433 http://dx.doi.org/10.3390/jcm11154343 |
_version_ | 1784758198637428736 |
---|---|
author | Kusan, Simon Surat, Güzin Kelm, Matthias Anger, Friedrich Kim, Mia Germer, Christoph-Thomas Schlegel, Nicolas Flemming, Sven |
author_facet | Kusan, Simon Surat, Güzin Kelm, Matthias Anger, Friedrich Kim, Mia Germer, Christoph-Thomas Schlegel, Nicolas Flemming, Sven |
author_sort | Kusan, Simon |
collection | PubMed |
description | Intraabdominal abscess formation occurs in up to 30% of patients suffering from Crohn´s disease (CD). While international guidelines recommend a step-up approach with a combination of empiric antibiotic therapy and percutaneous drainage to delay or even avoid surgery, evidence about microbial spectrum in penetrating ileitis is sparse. We retrospectively assessed outcomes of 46 patients with terminal penetrating Ileitis where microbial diagnostics have been performed and compared microbial spectrum and antibiotic resistance profile of CD patients with patients suffering from diverticulitis with intraabdominal abscess formation. In both groups, the most frequently isolated pathogen was the gram-negative bacterium E. coli belonging to the family of Enterobacterales. However, overall Enterobacterales were significantly more often verifiable in the control group than in CD patients. Furthermore, microbial analysis showed significant differences regarding isolation of anaerobic pathogens with decreased frequency in patients with CD. Subgroup analysis of CD patients to evaluate a potential influence of immunosuppressive therapy on microbial spectrum only revealed that Enterobacterales was less frequently detected in patients treated with steroids. Immunosuppressive therapy did not show any impact on all other groups of pathogens and did not change antibiotic resistance profile of CD patients. In conclusion, we were able to demonstrate that the microbial spectrum of CD patients does differ only for some pathogen species without increased rate of antibiotic resistance. However, the empiric antibiotic therapy for CD-associated intra-abdominal abscess remains challenging since different points such as local epidemiological and microbiological data, individual patient risk factors, severity of infection, and therapy algorithm including non-surgical and surgical therapy options should be considered before therapeutical decisions are made. |
format | Online Article Text |
id | pubmed-9330589 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-93305892022-07-29 Microbial Spectrum and Antibiotic Resistance in Patients Suffering from Penetrating Crohn’s Disease Kusan, Simon Surat, Güzin Kelm, Matthias Anger, Friedrich Kim, Mia Germer, Christoph-Thomas Schlegel, Nicolas Flemming, Sven J Clin Med Article Intraabdominal abscess formation occurs in up to 30% of patients suffering from Crohn´s disease (CD). While international guidelines recommend a step-up approach with a combination of empiric antibiotic therapy and percutaneous drainage to delay or even avoid surgery, evidence about microbial spectrum in penetrating ileitis is sparse. We retrospectively assessed outcomes of 46 patients with terminal penetrating Ileitis where microbial diagnostics have been performed and compared microbial spectrum and antibiotic resistance profile of CD patients with patients suffering from diverticulitis with intraabdominal abscess formation. In both groups, the most frequently isolated pathogen was the gram-negative bacterium E. coli belonging to the family of Enterobacterales. However, overall Enterobacterales were significantly more often verifiable in the control group than in CD patients. Furthermore, microbial analysis showed significant differences regarding isolation of anaerobic pathogens with decreased frequency in patients with CD. Subgroup analysis of CD patients to evaluate a potential influence of immunosuppressive therapy on microbial spectrum only revealed that Enterobacterales was less frequently detected in patients treated with steroids. Immunosuppressive therapy did not show any impact on all other groups of pathogens and did not change antibiotic resistance profile of CD patients. In conclusion, we were able to demonstrate that the microbial spectrum of CD patients does differ only for some pathogen species without increased rate of antibiotic resistance. However, the empiric antibiotic therapy for CD-associated intra-abdominal abscess remains challenging since different points such as local epidemiological and microbiological data, individual patient risk factors, severity of infection, and therapy algorithm including non-surgical and surgical therapy options should be considered before therapeutical decisions are made. MDPI 2022-07-26 /pmc/articles/PMC9330589/ /pubmed/35893433 http://dx.doi.org/10.3390/jcm11154343 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kusan, Simon Surat, Güzin Kelm, Matthias Anger, Friedrich Kim, Mia Germer, Christoph-Thomas Schlegel, Nicolas Flemming, Sven Microbial Spectrum and Antibiotic Resistance in Patients Suffering from Penetrating Crohn’s Disease |
title | Microbial Spectrum and Antibiotic Resistance in Patients Suffering from Penetrating Crohn’s Disease |
title_full | Microbial Spectrum and Antibiotic Resistance in Patients Suffering from Penetrating Crohn’s Disease |
title_fullStr | Microbial Spectrum and Antibiotic Resistance in Patients Suffering from Penetrating Crohn’s Disease |
title_full_unstemmed | Microbial Spectrum and Antibiotic Resistance in Patients Suffering from Penetrating Crohn’s Disease |
title_short | Microbial Spectrum and Antibiotic Resistance in Patients Suffering from Penetrating Crohn’s Disease |
title_sort | microbial spectrum and antibiotic resistance in patients suffering from penetrating crohn’s disease |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330589/ https://www.ncbi.nlm.nih.gov/pubmed/35893433 http://dx.doi.org/10.3390/jcm11154343 |
work_keys_str_mv | AT kusansimon microbialspectrumandantibioticresistanceinpatientssufferingfrompenetratingcrohnsdisease AT suratguzin microbialspectrumandantibioticresistanceinpatientssufferingfrompenetratingcrohnsdisease AT kelmmatthias microbialspectrumandantibioticresistanceinpatientssufferingfrompenetratingcrohnsdisease AT angerfriedrich microbialspectrumandantibioticresistanceinpatientssufferingfrompenetratingcrohnsdisease AT kimmia microbialspectrumandantibioticresistanceinpatientssufferingfrompenetratingcrohnsdisease AT germerchristophthomas microbialspectrumandantibioticresistanceinpatientssufferingfrompenetratingcrohnsdisease AT schlegelnicolas microbialspectrumandantibioticresistanceinpatientssufferingfrompenetratingcrohnsdisease AT flemmingsven microbialspectrumandantibioticresistanceinpatientssufferingfrompenetratingcrohnsdisease |